MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000362399

Медицинская библиотека · Oncology research and treatment · 2014

Single-center experience in the treatment of primary testicular lymphoma.

Mihaljevic Biljana, Vukovic Vojin, Smiljanic Mihailo, Milic Natasa, Todorovic Milena, Bila Jelena, Andjelic Bosko, Djurasinovic Vladislava, Jelicic Jelena, Antic Darko

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

Primary testicular lymphoma (PTL) is a rare and highly aggressive extranodal non-Hodgkin's lymphoma.

PATIENTS AND

METHODS

We evaluated the clinical and histopathological features and outcomes of 10 PTL patients treated in the period of 2003-2013 with multimodal therapy (rituximab, CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), intrathecal prophylaxis, irradiation of the contralateral testis) following orchiectomy.

RESULTS

Complete remission was achieved in 8 patients after first-line therapy while 2 patients had disease progression. The median follow-up duration was 30 months (range 6-110 months). Relapse occurred in 3 patients. 1 patient relapsed in the contralateral testis, while the other 2 patients relapsed to the skin and the central nervous system (CNS), respectively. The time to relapse was 2, 8, and 9 months. Patients with disease progression and relapse received ESHAP (etoposide, methylprednisolone, cytarabine, and cisplatin) as salvage treatment, except for 1 patient who was treated with palliative radiotherapy. After second-line therapy, only 1 patient had a short partial remission of 2 months. The median overall survival was 48 months, and the mean progression-free survival was 36 months (the median was not reached).

CONCLUSIONS

We evaluated 10 patients with PTL treated with rituximab plus CHOP, prophylactic intrathecal chemotherapy, and prophylactic irradiation of the contralateral testis, resulting in good outcome and low incidence of relapse in the contralateral testis; however, the benefit of intrathecal chemotherapy is not yet confirmed.

Для цитирования: Mihaljevic Biljana, Vukovic Vojin, Smiljanic Mihailo, Milic Natasa, Todorovic Milena, Bila Jelena, Andjelic Bosko, Djurasinovic Vladislava, Jelicic Jelena, Antic Darko. Single-center experience in the treatment of primary testicular lymphoma.. Oncology research and treatment. 2014. DOI: 10.1159/000362399.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.